Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ EDG8 Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA5142495
This item is not returnable.
View return policy
Description
This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:2,000.
The lysosphingolipid sphingosine 1-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Its actions may be both intracellular as a second messenger and extracellular as a receptor ligand. S1P and the structurally related lysolipid mediator lysophosphatidic acid (LPA) signal cells through a set of G protein-coupled receptors known as EDG receptors. Some EDG receptors (e.g., EDG1) are S1P receptors; others (e.g., EDG2) are LPA receptors.
Specifications
| EDG8 | |
| Polyclonal | |
| Unconjugated | |
| S1PR5 | |
| Edg8; Edg-8; endothelial differentiation G-protein-coupled receptor 8; endothelial differentiation, sphingolipid G-protein-coupled receptor, 8; lpB4; Lysophospholipid receptor B4; nerve growth factor-regulated G-protein-coupled receptor 1; Nrg1; NRG-1; S1P receptor 5; S1P receptor Edg-8; S1P(5) receptor; S1P5; S1PR5; Sphingosine 1-phosphate receptor 5; sphingosine 1-phosphate receptor EDG8; sphingosine 1-phosphate receptor Edg-8; sphingosine-1-phosphate receptor 5; sphingosine-1-phosphate receptor LPB4; SPPR-1; SPPR-2 | |
| Goat | |
| Ammonium sulfate precipitation | |
| RUO | |
| 53637 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| Q9H228 | |
| S1PR5 | |
| Peptide with sequence C-SGSERSSPQRDGLD. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction